NCT02244255View on ClinicalTrials.gov

FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia

PHASE4CompletedINTERVENTIONAL
Enrollment

1,993

Participants

Timeline

Start Date

August 31, 1998

Primary Completion Date

June 30, 2000

Conditions
Prostatic Hyperplasia
Interventions
DRUG

FLOMAX® capsules

DRUG

Ascending doses of HYTRIN® capsules

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY